KaloBios Pharmaceuticals Inc, which fired its controversial Chief Executive Martin Shkreli earlier this month, said it had requested an appeal of Nasdaq's decision to delist its shares.
The embattled drugmaker said last week it had been notified by Nasdaq that its stock would be delisted using the exchange operator's "discretionary" authority.
Also read: Caterpillar Says Sales Woes Could Linger
14:35 Kim Zolciak Gets 'Cellulite Dimples' Injected With Filler — Watch The NSFW Procedure HERE!8
12:23 Lockheed Martin's quarterly profit handily beats estimates12
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents11
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T3